Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-046680
Filing Date
2011-08-15
Accepted
2011-08-15 11:29:31
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v231378_10q.htm 10-Q 746149
2 EXHIBIT 4.1 v231378_ex4-1.htm EX-4.1 16813
3 EXHIBIT 31 v231378_ex31.htm EX-31 9965
4 EXHIBIT 32 v231378_ex32.htm EX-32 6765
  Complete submission text file 0001144204-11-046680.txt   2217136

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT iccc-20110630.xml EX-101.INS 198165
6 XBRL TAXONOMY EXTENSION SCHEMA iccc-20110630.xsd EX-101.SCH 13910
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iccc-20110630_cal.xml EX-101.CAL 26154
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iccc-20110630_def.xml EX-101.DEF 62403
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE iccc-20110630_lab.xml EX-101.LAB 146414
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iccc-20110630_pre.xml EX-101.PRE 87077
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 111034198
SIC: 2835 In Vitro & In Vivo Diagnostic Substances